Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 359 of 1,261
  1. US 10946033

    2′-substituted-N6-substituted purine nucleotides for RNA virus treatment

    Atea Pharmaceuticals, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  2. US 10946023

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  3. US 10946007

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  4. US 10946006

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Theravance Biopharma R&D IP, LLC · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  5. US 10946000

    Method for treating cancer with combination therapy

    RedHill Biopharma Ltd. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  6. US 10947507

    Platform for generating safe cell therapeutics

    The Regents of the University of California · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  7. US 10945996

    Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  8. US 10946005

    Methods for shrinking pituitary tumors

    Corcept Therapeutics Incorporated · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  9. US 10945993

    Methods of recruiting SDF-producing macrophages

    MedRegen, LLC · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  10. US 10945972

    Particulate materials

    Nektar Therapeutics · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  11. US 10947257

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  12. US 10947206

    cGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  13. US 10947310

    Fusion protein comprising apelin and an anti-APLNR antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  14. US 10947224

    Hepatitis B core protein allosteric modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  15. US 10947509

    Cell populations, methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  16. US 10947207

    GP130 modulators

    The Regents of the University of California · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  17. US 10947317

    NaPi2b-targeted antibody-drug conjugates and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  18. US 10947033

    Reduction in stress cracking of films

    Aquestive Therapeutics, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  19. US 10945962

    Controlled-release peptide compositions and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  20. US 10945503

    Systems, devices and methods for styling hair

    MIRAKEL TECHNOLOGIES, INC. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  21. US 10947306

    Correctly folded etanercept in high purity and excellent yield

    Coherus BioSciences, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  22. US 10947295

    Heterodimers of soluble interferon receptors and uses thereof

    Sanabio, LLC · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  23. US 10948495

    Methods and reagents for analyzing protein-protein interfaces

    Revolution Medicines, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  24. US 10947177

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.